Something Different

RFP: Climate-Sensitive Infectious Disease Modelling

Dear All, And now for something really different! With the recent GRAM report (20 Jan 2022 newsletter) showing that AMR is linked to more deaths that HIV or malaria (#AMRSOS! Andrew Jack and FT team have some great graphics for this … check them out!), we now have an absolutely fascinating call from Wellcome Trust for

Read More »

Young people and AMR: A global summit! A video game!

Dear All, Today we have two hopeful signs from our younger colleagues about the future of AMR! First Global AMR Youth SummitThe World Health Students’ Alliance (WHSA) has announced a 3-day virtual event (20-22 Nov 2020, see details below) where “youth around the world come together to discuss, learn, and get empowered about various AMR-related

Read More »

PBS FRONTLINE: Hunting the Nightmare Bacteria

Dear All:  Frontline will today broadcast an updated version of the excellent Hunting the Nightmare Bacteria show that first broadcast in 2013. Here’s the link to the announcement and here is the short description of this 1-h program: “Described by the Centers for Disease Control and Prevention as “nightmare bacteria,” there are now predictions that drug-resistant superbugs will kill more

Read More »

Superb PBS Newshour segment on agricultural use of antibiotics + McKeena’s Big Chicken book

Dear All:  I wrote a few weeks ago about the Stopping Superbugs series from PBS Newshour. PBS has since then added some superb new materials: A marvelous 10-minute video story on agricultural use of antibiotics A column on Maryn McKenna’s upcoming Big Chicken book (scheduled for release on 12 Sep) A column on the never-ending debate about taking the entire course of antibiotics These build on

Read More »

Future Leaders Against AMR – Fireside Chat with Founder!

Dear All, As some of you may have seen on Twitter, the Future Leaders Against AMR have been busy! I was honored to speak to the group of 40 international young people as part of their lecture series. Future Leaders Against AMR is supported by the PAR Foundation and, once I realized the grassroots nature of the

Read More »

Discussing Details of ATMF’s 2021 AMR Benchmark Report!

Dear All, As you may remember, last fall I wrote a newsletter about ATMF’s 3rd update to the AMR Benchmark series. You are encouraged to read the report but in brief, the key messages are (i) the pipeline is small with most innovation coming from small biotech, (ii) stewardship and access planning are increasingly seen (but

Read More »

RFP: Gender inequality in AMR (with a focus on sub-Saharan Africa)

Dear All, Continuing with the theme of socio-economic inequality and AMR that we discussed in prior newsletters (31 Jan 2022, “RFP: Support For Creating Antimicrobial Stewardship Centers Of Excellence” and 26 Oct 2021, “$50-100k Grants To Address Socioeconomic Outcome Disparities Due To AMR-Related Factors”), we today have an RFP on gender and AMR from the

Read More »

WHO 2020 clinical/preclinical pipeline review; Chat with WHO’s Peter Beyer

Dear All, WHO have today updated their 2019 clinical/preclinical pipeline review by releasing their 2020 analyses of both the clinical and pre-clinical antibacterial product pipelines (the new 2020 report, the press release). Their 2020 review of antibacterial products in Phase 1 and beyond covers both traditional (n = 43) and non-traditional products (n = 27)

Read More »
Scroll to Top